Biogen Idec and Conforma Therapeutics Corporation, a privately held biopharmaceutical company focused on the design and development of novel drugs for the treatment of cancer, recently announced that they have signed a definitive merger agreement for the acquisition of Conforma by Biogen Idec.
Financial News USA
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
FDA OKs Device for Treating Heart Failure
The physician tests and programs the device after implementation.
Illinois Man Gets Five Years in Phony Pharmacy Scam
Calhoun obtained scrips for Arixtra, an expensive daily injection used to treat or prevent blood clots.
FDAnews Drug Daily Bulletin
BIOGEN IDEC TO EXPAND ONCOLOGY PIPELINE
May 5, 2006
